Stay updated on Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T23:13:19.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed information about a Phase II clinical trial for a treatment involving Sacituzumab Govitecan and Pembrolizumab for metastatic triple-negative breast cancer. Additionally, the names of collaborators and the principal investigator have been updated.
    Difference
    48%
    Check dated 2025-04-17T08:07:29.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-10T05:13:27.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-25T19:07:14.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.8%
    Check dated 2025-02-11T07:28:11.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-04T02:44:23.000Z thumbnail image

Stay in the know with updates to Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.